HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Study of trisomy 22 and inversion 16 in acute myeloid leukemia].

AbstractOBJECTIVE:
To explore the value of trisomy 22 ( +22) in the diagnosis of inv(16) acute myeloid leukemia (AML).
METHODS:
Interphase fluorescence in situ hybridization (FISH) was performed in 18 AML patients with +22. The probe was two-color break apart probe for CBFbeta with SpectrumRed on the centromeric side and SpectrumGreen on the telomeric side. The FISH results were compared with that of R-banding conventional cytogenetics (CC). Multiplex FISH (M-FISH) was used to analyze the relationship of +22 and inv(16).
RESULTS:
CC revealed inv(16) in none of the 18 AML, with +22, but FISH revealed inv (16) in 11 of them and del( 16) (q22) in one. As CC results, 9 of the 11 cases were sole +22, one complicated with trisomy 8, and one del(16) (q22). Four patients with +22 and inv(16) were analyzed by M-FISH and revealed +22 only.
CONCLUSION:
+22 can be regarded as an important marker for the diagnosis of inv(16) AML.
AuthorsHui-fen Zhou, Jian-yong Li, Jin-lan Pan, Hai-rong Qiu, Li-juan Chen, Jie-ying Hu, Yun-feng Shen, Wei Xu, Yong-quan Xue
JournalZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi (Zhonghua Xue Ye Xue Za Zhi) Vol. 28 Issue 1 Pg. 11-4 (Jan 2007) ISSN: 0253-2727 [Print] China
PMID17649718 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Aged
  • Chromosome Inversion
  • Chromosomes, Human, Pair 16 (genetics)
  • Chromosomes, Human, Pair 22 (genetics)
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Leukemia, Myeloid, Acute (genetics)
  • Male
  • Middle Aged
  • Trisomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: